Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial - Andreas Hüttmann, Jan Rekowski, Stefan P. Müller, Bernd Hertenstein, Christiane Franzius, Rolf Mesters, Matthias Weckesser, Frank Kroschinsky, Jörg Kotzerke, Arnold Ganser, Frank M. Bengel, Paul La Rosée, Martin Freesmeyer, Heinz-Gert Höffkes, Andreas Hertel - Dissemin

Language
Login

Published in

Springer (part of Springer Nature), Annals of Hematology, 4(98), p. 897-907, 2019

DOI: 10.1007/s00277-018-3578-0

Links

Springer (part of Springer Nature)

Tools

Export citation

Search in Google Scholar

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial

Journal article published in 2019 by Andreas Hüttmann, Jan Rekowski, Stefan P. Müller, Bernd Hertenstein, Christiane Franzius, Rolf Mesters, Matthias Weckesser, Frank Kroschinsky, Jörg Kotzerke, Arnold Ganser, Frank M. Bengel, Paul La Rosée, Martin Freesmeyer, Heinz-Gert Höffkes, Andreas Hertel and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Green circle

Postprint: archiving allowed

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO